1. Home
  2. BWAY vs SMID Comparison

BWAY vs SMID Comparison

Compare BWAY & SMID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • SMID
  • Stock Information
  • Founded
  • BWAY 2003
  • SMID 1960
  • Country
  • BWAY Israel
  • SMID United States
  • Employees
  • BWAY N/A
  • SMID N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • SMID Building Materials
  • Sector
  • BWAY Health Care
  • SMID Industrials
  • Exchange
  • BWAY Nasdaq
  • SMID Nasdaq
  • Market Cap
  • BWAY 207.4M
  • SMID 181.0M
  • IPO Year
  • BWAY 2019
  • SMID 1995
  • Fundamental
  • Price
  • BWAY $10.38
  • SMID $33.95
  • Analyst Decision
  • BWAY Strong Buy
  • SMID
  • Analyst Count
  • BWAY 3
  • SMID 0
  • Target Price
  • BWAY $13.17
  • SMID N/A
  • AVG Volume (30 Days)
  • BWAY 93.8K
  • SMID 8.1K
  • Earning Date
  • BWAY 03-11-2025
  • SMID 11-14-2024
  • Dividend Yield
  • BWAY N/A
  • SMID N/A
  • EPS Growth
  • BWAY N/A
  • SMID 1025.92
  • EPS
  • BWAY 0.09
  • SMID 1.22
  • Revenue
  • BWAY $41,016,000.00
  • SMID $76,366,000.00
  • Revenue This Year
  • BWAY $349.63
  • SMID N/A
  • Revenue Next Year
  • BWAY $27.16
  • SMID N/A
  • P/E Ratio
  • BWAY $62.47
  • SMID $27.43
  • Revenue Growth
  • BWAY 29.04
  • SMID 32.40
  • 52 Week Low
  • BWAY $4.61
  • SMID $25.03
  • 52 Week High
  • BWAY $11.79
  • SMID $51.96
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 52.06
  • SMID 37.49
  • Support Level
  • BWAY $8.88
  • SMID $31.09
  • Resistance Level
  • BWAY $10.54
  • SMID $35.87
  • Average True Range (ATR)
  • BWAY 0.55
  • SMID 1.92
  • MACD
  • BWAY 0.03
  • SMID 0.09
  • Stochastic Oscillator
  • BWAY 66.39
  • SMID 26.33

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

Share on Social Networks: